Standardizing the Morphology Framework
Current clinical practice relies heavily on morphological parameters defined by international consensus, including the ESHRE and Alpha Scientists criteria. The primary benchmarks for grading include the number of blastomeres, the presence of cytoplasmic fragmentation, blastomere symmetry, and the absence of multinucleation. These features are generally evaluated on Day 2 and Day 3, with 7-9 blastomeres often considered the gold standard for transfer potential.
Evidence consistently shows that heavy fragmentation (>25%) is an adverse indicator, correlating with higher apoptosis rates and poorer clinical outcomes. However, the interpretation of these features is subject to significant inter-observer variability, necessitating rigorous internal training and standardization protocols to maintain quality control.
Morphokinetics vs. Static Snapshot
With the advent of time-lapse imaging, the field has gained the ability to monitor developmental milestones such as the 'first cleavage-associated compensatory timing' (FACT). While these dynamic markers provide detailed biological insights, high-quality RCT evidence has not yet definitively shown that time-lapse systems significantly outperform conventional static assessment regarding live birth rates.
Furthermore, extrinsic factors like the composition of culture media are known to alter embryonic kinetics, which complicates the universal application of specific timing algorithms.